Publications by authors named "A Lintermans"

Claim this Profile
F
Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken.
Y Piette, F Van den Bossche, J Aerts, N Aerts, S Ajeganova, A Lintermans

Acta Clin Belg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Patrick Neven, Lynn Jongen, Anneleen Lintermans, Kathleen Van Asten, Chantal Blomme

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.
N Lynn Henry, Kelly Speth, Anneleen Lintermans, Kelley M Kidwell, Rachel Carlson

Clin Breast Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
A Lintermans, K Van Asten, L Jongen, T Van Brussel, A Laenen

Eur J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of aromatase inhibitor therapy in breast cancer.
Anneleen Lintermans, Patrick Neven

Expert Opin Drug Saf· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis